Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy MagazineNOW IN
    Article

    Development and Evaluation of Sesamol-Loaded Self Nanoemulsifying Drug Delivery System for Breast Cancer

    Namrata Singh1,2, Poonam Kushwaha1★, Amresh Gupta2, Akash Ved3, Shivam Swarup4★ Corresponding author

    1. 1Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India.
    2. 2Goel Institute of Pharmacy and Sciences, Lucknow, Uttar Pradesh, India.
    3. 3Goel Institute of Pharmaceutical Sciences, Lucknow, Uttar Pradesh, India.
    4. 4Dabur India Ltd, Ghaziabad, Uttar Pradesh, India.

    CORRESPONDENCE

    Poonam Kushwaha

    Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India.

    poonam.kushwaha083@gmail.com

    Received: 06-06-2021; Revised: 22-07-2021; Accepted: 09-09-2021.

    Volume 18, Issue 77 · pp. 94–102 · PUBLISHED 28 March 2022 · DOI: 10.4103/pm.pm_248_21

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Objectives: In the present study, Sesamol‑loaded SNEDDS were developed, identified, and assessed for the enhancement of its in vitro dissolution rate and anticancer efficacy. Materials and Methods: Based on the solubilization potential of sesamol, the oil (Isopropyl myristate, Isopropyl palmitate, Caprylic capric triglycerides, Sesame oil) surfactant (Span 80, and Tween 80), and cosurfactant (Poly Ethylene Glycol 400) were chosen for the formulation of Sesamol‑loaded SNEDDS. SNEDDS were prepared by an aqueous titration technique. Developed formulations were characterized and assessed for thermodynamic stability, self nanoemulsification efficiency, droplet size, polydispersity index, zeta potential, surface morphology, refractive index, the percent of transmittance, and drug release profile. Results: In vitro dissolution rate of Sesamol was significantly enhanced from the optimized formulation in comparison with pure drug. The finalized formulation was selected for in vitro anticancer effects in human breast cancer cells (MCF‑7) by 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑Diphenyl Tetrazolium Bromide (MTT) assay. MTT assay suggested remarkable anticancer efficacy of finalized Sesamol‑loaded SNEDDS against MCF‑7 cells compared with standard (Marketed preparation). Conclusion: The outcome of this study revealed the incredible potential of SNEDDS in the enhancement of in vitro dissolution rate and anticancer efficacy of the poorly soluble drug.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Singh, N., Kushwaha, P., Gupta, A., Ved, A., & Swarup, S. (2022). Development and Evaluation of Sesamol-Loaded Self Nanoemulsifying Drug Delivery System for Breast Cancer. Pharmacognosy Magazine, 18(77), 94–102. https://doi.org/10.4103/pm.pm_248_21